Semaphorin CD100 from Activated T Lymphocytes Induces Process Extension Collapse in Oligodendrocytes and Death of Immature Neural Cells

Journal of Immunology

Volumn 172, Issue 2, 2004, Pages 1246-1255

  Giraudon, Pascale ^a,d   Vincent, Peggy ^a   Vuaillat, Carine ^a   Verlaeten, Olivier ^a   Cartier, Luis ^c   Marie Cardine, Anne ^b   Mutin, Mireille ^a   Bensussan, Armand ^b   Belin, Marie Françoise ^a   Boumsell, Laurence ^b  

^a Centre de Recherche et Nutrition Humaine   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c UNIVERSITY OF CHILE   (Chile)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE FIBER DEGENERATION; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; REMYELINIZATION; RETROVIRUS INFECTION; SPINAL CORD; SPINAL CORD DISEASE; STEM CELL; T LYMPHOCYTE;

EID: 9144260557     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.2.1246     Document Type: Article

References (54)

1. Boulanger, L. M., G. S. Huh, and C. J. Shatz. 2001. Neuronal plasticity and cellular immunity: shared molecular mechanisms. Curr. Opin. Neurobiol. 11:568.
2. Liu, B. P., and S. M. Strittmatter. 2001. Semaphorin-mediated axonal guidance via Rho-related G proteins. Curr. Opin. Cell Biol. 13:619.
3. Kolodkin, A. L., D. J. Matthes, T. P. O'Connor, N. H. Patel, A. Admon, D. Bentley, and C. S. Goodman. 1992. Fasciclin IV: sequence, expression, and function during growth cone guidance in the grasshopper embryo. Neuron 9:831.
4. Chisholm, A., and M. Tessier-Lavigne. 1999. Conservation and divergence of axon guidance mechanisms. Curr. Opin. Neurobiol. 9:603.
5. Hall, K. T., L. Boumsell, J. L. Schultze, V. A. Boussiotis, D. M. Dorfman, A. A. Cardoso, A. Bensussan, L. M. Nadler, and G. J. Freeman. 1996. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc. Natl. Acad. Sci. USA 93:11780.
6. Kumanogoh, A., S. Marukawa, K. Suzuki, N. Takegahara, C. Watanabe, E. Ch'ng, I. Ishida, H. Fujimura, S. Sakoda, K. Yoshida, and H. Kikutani. 2002. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419:629.
7. Bismuth, G., and L. Boumsell. 2002. Controlling the immune system through semaphorins. Sci. STKE 2002:RE4.
8. Suzuki, K., A. Kumanogoh, and H. Kikutani. 2003. CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses. Cytokine Growth Factor Rev. 14:17.
9. Kumanogoh, A., and H. Kikutani. 2001. The CD100-CD72 interaction: a novel mechanism of immune regulation. Trends Immunol. 22:670.
10. Wang, X., A. Kumanogoh, C. Watanabe, W. Shi, K. Yoshida, and H. Kikutani. 2001. Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 97:3498.
11. Goshima, Y., T. Ito, Y. Sasaki, and F. Nakamura. 2002. Semaphorins as signals for cell repulsion and invasion. J. Clin. Invest. 109:993.
12. Bagnard, D., C. Vaillant, S. T. Khuth, N. Dufay, M. Lohrum, A. W. Puschel, M. F. Belin, J. Bolz, and N. Thomasset. 2001. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J. Neurosci. 21:3332.
13. Ricard, D., V. Rogemond, E. Charrier, M. Aguera, D. Bagnard, M. F. Belin, N. Thomasset, and J. Honnorat. 2001. Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a-sensitive oligodendrocytes. J. Neurosci. 21:7203.
14. Shirvan, A., R. Shina, I. Ziv, E. Melamed, and A. Barzilai. 2000. Induction of neuronal apoptosis by Semaphorin3A-derived peptide. Brain Res. Mol. Brain Res. 83:81.
15. Delaire, S., C. Billard, R. Tordjman, A. Chedotal, A. Elhabazi, A. Bensussan, and L. Boumsell. 2001. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J. Immunol. 166:4348.
16. Tordjman, R., Y. Lepelletier, V. Lemarchandel, M. Cambot, P. Gaulard, O. Hermine, and P. H. Romeo. 2002. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat. Immun. 3:477.
17. Elhabazi, A., S. Delaire, A. Bensussan, L. Boumsell, and G. Bismuth. 2001. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J. Immunol. 166:4341.
18. Prineas, J. W., R. O. Barnard, T. Revesz, E. E. Kwon, L. Sharer, and E. S. Cho. 1993. Multiple sclerosis: pathology of recurrent lesions. Brain 116:681.
19. Cartier, L. M., J. G. Cea, C. Vergara, F. Araya, and P. Born. 1997. Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-1: an axomyelinic degeneration of the central nervous system. J. Neuropathol. Exp. Neurol. 56:403.
20. Osame, M., K. Arimura, M. Nakagawa, F. Umehara, K. Usuku, and S. Ijichi. 1997. HTLV-1 associated myelopathy (HAM): review and recent studies. Leukemia 11(Suppl. 3):63.
21. t Hart, B. A., H. P. Brok, S. Amor, and R. E. Bontrop. 2001. The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels. Hum. Immunol. 62:1371.
22. Jacobson, S. 2002. Immunopathogenesis of human T cell lymphotropic virus type 1-associated neurologic disease. J. Infect. Dis. 186(Suppl. 2):S187.
23. Cuzner, M. L., D. Gveric, C. Strand, A. J. Loughlin, L. Paemen, G. Opdenakker, and J. Newcombe. 1996. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol Exp. Neurol. 55:1194.
24. + T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99:88.
25. Grant, C., K. Barmak, T. Alefantis, J. Yao, S. Jacobson, and B. Wigdahl. 2002. Human T cell leukemia virus type 1 and neurological disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J. Cell. Physiol. 190:133.
26. Blakemore, W. F., and R. J. Franklin. 2000. Transplantation options for therapeutic central nervous system remyelination. Cell Transplant. 9:289.
27. Chang, A., W. W. Tourfellotte, R. Rudick, and B. D. Trapp. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346:165.
28. Homer, P. J., A. E. Power, G. Kempermann, H. G. Kuhn, T. D. Palmer, J. Winkler, L. J. Thal, and F. H. Gage. 2000. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J. Neurosci. 20:2218.
29. Narayanan, S., L. Fu, E. Pioro, N. De Stefano, D. L. Collins, G. S. Francis, J. P. Antel, P. M. Matthews, and D. L. Arnold. 1997. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann. Neurol. 41:385.
30. Howard, A. K., D. K. Li, and J. Oger. 2003. MRI contributes to the differentiation between MS and HTLV-1 associated myelopathy in British Columbian coastal natives. Can. J. Neurol. Sci. 30:41.
31. Coleman, M. P., and V. H. Perry. 2002. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25:532.
32. De Winter, F., M. Oudega, A. J. Lankhorst, F. P. Hamers, B. Blits, M. J. Ruitenberg, R. J. Pasterkamp, W. H. Gispen, and J. Verhaagen. 2002. Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp. Neurol. 175:61.
33. Zhang, S. C., B. Ge, and I. D. Duncan. 1999. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc. Natl. Acad. Sci. USA 96:4089.
34. Popovic, M., G. Lange-Wantzin, P. S. Sarin, D. Mann, and R. C. Gallo. 1983. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc. Natl. Acad. Sci. USA 80:5402.
35. Giraudon, P., R. Szymocha, S. Buart, A. Bernard, L. Cartier, M. F. Belin, and H. Akaoka. 2000. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-1-induced neurological disease. J. Immunol. 164:2718.
36. Derrington, E. A., N. Dufay, B. B. Rudkin, and M. F. Belin. 1998. Human primitive neuroectodermal tumor cells behave as multipotent neural precursors in response to FGF2. Oncogene 17:1663.
37. Buzanska, L., N. Spassky, M. F. Belin, A. Giangrande, F. Guillemot, C. Klambt, M. Labouesse, J. L. Thomas, K. Domanska-Janik, and B. Zalc. 2001. Human medulloblastoma cell line DEV is a potent tool to screen for factors influencing differentiation of neural stem cells. J. Neurosci. Res. 65:17.
38. Szymocha, R., H. Akaoka, M. Duluit, C. Malcus, M. Didier-Bazes, M. F. Belin, and P. Giraudon. 2000. Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor α. J. Virol. 74:6433.
39. Tamagnone, L., S. Artigiani, H. Chen, Z. He, G. I. Ming, H. Song, A. Chedotal, M. L. Winberg, C. S. Goodman, M. Poo, et al. 1999. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99:71.
40. Giraudon, P., S. Buart, A. Bernard, N. Thomasset, and M. F. Belin. 1996. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Prog. Neurobiol. 49:169.
41. Umehara, F., Y. Okada, N. Fujimoto, M. Abe, S. Izumo, and M. Osame. 1998. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 57:839.
42. Neuhaus, O., J. J. Archelos, and H. P. Hartung. 2003. Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection. Trends Pharmacol. Sci. 24:131.
43. Steinman, L. 2001. Multiple sclerosis: a two-stage disease. Nat. Immun. 2:762.
44. Bjartmar, C., and B. D. Trapp. 2001. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr. Opin. Neurol. 14:271.
45. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H. L. Weiner, and D. A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973.
46. Lassmann, H. 2002. Mechanisms of demyelination and tissue destruction in multiple sclerosis. Clin. Neurol. Neurosurg. 104:168.
47. Pasterkamp, R. J., and J. Verhaagen. 2001. Emerging roles for semaphorins in neural regeneration. Brain Res. Brain Res. Rev. 35:36.
48. Levine, J. M., R. Reynolds, and J. W. Fawcett. 2001. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 24:39.
49. Leist, M., and M. Jaattela. 2001. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2:589.
50. Wolswijk, G. 2002. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125:338.
51. Levin, M. C., M. Krichavsky, J. Berk, S. Foley, M. Rosenfeld, J. Dalmau, G. Chang, J. B. Posner, and S. Jacobson. 1998. Neuronal molecular mimicry in immune-mediated neurologic disease. Ann. Neurol. 44:87.
52. Shi, W., A. Kumanogoh, C. Watanabe, J. Uchida, X. Wang, T. Yasui, K. Yukawa, M. Ikawa, M. Okabe, J. R. Parnes, et al. 2000. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 13:633.
53. Kikutani, H., and A. Kumanogoh. 2003. Semaphorins in interactions between T cells and antigen-presenting cells. Nat. Rev. Immunol. 3:159.
54. Versijpt, J., K. Van Laere, R. A. Dierckx, F. Dumont, P. P. De Deyn, G. Slegers, and J. Korf. 2003. Scintigraphic visualization of inflammation in neurodegenerative disorders. Nucl. Med. Commun. 24:209.